Concentrix Corp current report, 24 November 2020

Concentrix Corporation Form 8-K Summary

Business Context and Reporting Period

Concentrix filed this Current Report on November 24, 2020, with the report signed November 25, 2020. The filing concerns the continued service of Chris Caldwell as Chief Executive Officer following the planned tax-free spin-off of Concentrix from SYNNEX Corporation.

Financial and Compensation Metrics

  • Mr. Caldwell’s starting annual base salary will be $775,000.
  • For fiscal 2021, he will be eligible for an annual cash incentive award with a target equal to 2.5 times base salary, subject to performance goals established by the Compensation Committee.
  • His fiscal 2020 bonus opportunity remains based on the previously determined SYNNEX target, but will be paid by Concentrix. If less than 100% of the SYNNEX target is achieved, the bonus may be increased by 25%, subject to an aggregate maximum of $1,150,000.
  • Equity awards to be granted at or after the effective date of the spin-off include a stock option with an approximately $1.0 million fair value, restricted stock with an approximately $550,000 fair value, and restricted stock with a $10.0 million fair value.

The filing does not provide company revenue, profit, cash flow, margin, debt, liquidity, or other operating-financial metrics.

Material Changes Versus the Prior Comparable Period

The filing establishes post-spin-off compensation arrangements for the Chief Executive Officer. It does not present comparative financial results or identify changes in operating performance versus a prior period.

Guidance, Outlook, Risks, Contingencies, and Unusual Items

  • The fiscal 2021 incentive award will depend on performance goals determined by the Compensation Committee; the filing does not disclose those goals.
  • The equity awards are subject to specified vesting schedules and continued employment.
  • The offer letter provides for certain payments if Mr. Caldwell is terminated without cause, but the filing does not quantify those payments.
  • The offer letter includes non-competition and employee and client non-solicitation covenants.
  • The spin-off timing affects when the equity awards are expected to be granted: on the effective date of the spin-off or, if the market is closed, during the next open trading window.

Important Facts for Investors to Verify

  • Effective date and final terms of the SYNNEX-Concentrix spin-off.
  • Performance goals and actual payout under the fiscal 2021 incentive plan.
  • Final grant dates, valuation, dilution impact, and vesting of the three equity awards.
  • Termination-without-cause payment provisions in Exhibit 10.1.
  • Any subsequent filings reporting executive compensation, equity grants, or changes to the spin-off structure.